Clinical Trials Logo

Volunteers clinical trials

View clinical trials related to Volunteers.

Filter by:

NCT ID: NCT02949999 Completed - Volunteers Clinical Trials

Voclosporin in Healthy Japanese Volunteers

Start date: October 2016
Phase: Phase 1
Study type: Interventional

The study is a single-centre, double-blind, placebo controlled, randomized, ascending multiple dose study to assess the safety, tolerability, pharmacokinetics and pharmacodynamic profiles of voclosporin.

NCT ID: NCT02942667 Completed - Volunteers Clinical Trials

Magnetic Resonance Imaging of Human Biometrics

MRI HB
Start date: August 2016
Phase: N/A
Study type: Observational

The primary objective is to collect high quality MRI data (un-processed or processed) from participating subjects for Medtronic research purposes.

NCT ID: NCT02922946 Completed - Healthy Volunteers Clinical Trials

Study to Determine the Effect of the Timing of a Meal on the Pharmacokinetics of Entinostat

Start date: October 11, 2016
Phase: Phase 1
Study type: Interventional

The objectives of this study are to evaluate the effect of the timing of a moderate-fat meal on the single dose pharmacokinetics of entinostat and to evaluate the safety and tolerability of entinostat under fed and fasting conditions in healthy adult subjects.

NCT ID: NCT02922933 Completed - Healthy Volunteers Clinical Trials

A Study to Examine the Effect of Omeprazole, Famotidine, and an Acidic Beverage on the Pharmacokinetics of Entinostat in Healthy Adult Subjects

Start date: October 25, 2016
Phase: Phase 1
Study type: Interventional

The purpose of this study is therefore to evaluate the effect of concomitant drugs through an increase of intra-gastric pH levels on the bioavailability of entinostat. The primary objectives of this study are to evaluate the effect of multiple doses of omeprazole, famotidine, and the effect of an acidic beverage in combination with omeprazole on the single-dose PK profile of entinostat. The secondary objectives are to evaluate the safety and tolerability of a single dose of entinostat when administered with multiple doses of omeprazole, famotidine, and when administered with an acidic beverage in combination with omeprazole.

NCT ID: NCT02889042 Terminated - Volunteers Clinical Trials

Repeated Voluntary Drug Intoxication (IMVr): Characterization of a New Addictive Behavior by Clinical Phenotyping and Functional Imaging

Phenot IMVr
Start date: July 19, 2016
Phase: N/A
Study type: Interventional

France is one of the European countries with the highest rate of death by suicide, more than 10 400 deaths each year, about 16 people out of 100 000. Although suicide mortality rate tends to fall between 1987 and 2008 the number of suicide attempts (TS) against observed by an upward trend between 2005 and 2010. However, the most important predictor of death by suicide remains the TS. Now these are primarily TS Poisoning Drug-Volunteer (IMV), especially benzodiazepines. These IMV, there have been 16% recurrence in the past year and 21% at 4 years among hospitalized patients. Or a Health Barometer 2005 survey showed that 58% of respondents with a TS over the last 12 months had not been hospitalized. This type of acting out, especially the repeated IMV (IMVr) is underestimated epidemiologically because it is an unknown phenomenon and too little screened by health professionals.

NCT ID: NCT02622867 Completed - VOLUNTEERS Clinical Trials

Lactobacillus Plantarum 3547 Effects Over Inflammatory and Immunologic Markers

Start date: February 2013
Phase: Phase 4
Study type: Interventional

The purpose of this study is to evaluate the effects of the probiotic Lactobacillus plantarum 3547 over different inflammation and immune system markers on a healthy middle-aged group.

NCT ID: NCT02091271 Completed - Volunteers Clinical Trials

Screening Protocol to Evaluate Volunteers for NIA Approved Studies

Start date: February 28, 2003
Phase:
Study type: Observational

The National Institute on Aging (NIA) Intramural Research Program (IRP) has a number ofiRB approved research studies involving human subjects, both normal volunteers and patients. As a means of identifying interested volunteers and other participants in the research process, this screening mechanism is established to identif'y potential eligible participants for NlA protocols. To participate, volunteers/patients must meet the specific requirements of at least one of the available NlA research studies; this protocol serves as a first step for admitting volunteers/patients to an appropriate approved protocol and creating a contact database for approved NlA studies. This protocol will facilitate their recruitment into NIA approved studies and provide NlA staff the opportunity to examine subjects where diagnostic observations can be documented and evaluated for research potential.

NCT ID: NCT01974037 Completed - Volunteers Clinical Trials

Capsaicin on Salty Gustatory Cortices

Start date: May 2013
Phase: Phase 4
Study type: Interventional

Excess dietary salt intake is closely associated with the development of hypertension and cardiocerebral vascular diseases. Preference of high salt diet might involve salty gustatory cortices change. This study focuses on examining the neuroimaging changes of salty gustatory cortices under different concentration of NaCl solution with or without capsaicin intervention through brain PET/CT scan.

NCT ID: NCT01573988 Terminated - Volunteers Clinical Trials

Satiety, Meal Frequency and Nutritional Aspects

SAFRAN
Start date: August 2010
Phase: N/A
Study type: Interventional

In this study, the investigators are interested in assessing the effects of the isocaloric increase of eating frequency on appetite and metabolism. How the consumption of an isocaloric breakfast in four intakes vs. one can modify satiety and appetite control in lean and obese subjects through : - the physiological consequences : difference in postprandial kinetics of glucose, non esterified fatty acid, triglyceride, the secretion of satiety gut hormone (insulin, ghrelin, leptin and cholescystokinine (CCK), peptide YY (PYY), glucagon-like peptide-1 (GLP-1), nutrients oxidative fate and plasmatic oxidative stress (Malondialdehyde (MDA), glutathion, lipid hydroperoxides) - eating behavior during an ad libitum buffet test meal

NCT ID: NCT01121380 Terminated - Healthy Clinical Trials

A Study Intended to Evaluate Safety, Tolerability and Pharmacokinetics (PK) Parameters of BL-1021

Start date: June 2011
Phase: Phase 1
Study type: Interventional

The purpose of this study is to test the safety, tolerability and pharmacokinetics of BL-1021 in healthy volunteers. Subsequent clinical studies will be designed to test the safety and efficacy of BL-1021 in patients with neuropathic pain based on data obtained from the proposal trial described below.